ISRVF:OTC-iShares Public Limited Company - iShares MSCI Japan USD Hedged UCITS ETF (Acc) (USD)

ETF | Others |

Last Closing

USD 76.99

Change

-0.20 (-0.26)%

Market Cap

N/A

Volume

172.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

-0.80 (-0.13%)

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
ETHE Grayscale Ethereum Trust (ETH)

+0.37 (+1.43%)

USD 4.57B
EBCRY EBCRY

+5.12 (+50.01%)

USD 4.06B
SSEEF SSgA SPDR ETFs Europe I Public..

-0.19 (-0.25%)

USD 2.95B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B
ISRPF iShares Public Limited Company..

+0.86 (+0.86%)

USD 2.22B

ETFs Containing ISRVF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.03% 29% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.03% 29% F 43% F
Trailing 12 Months  
Capital Gain 16.09% 64% D 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.09% 62% D 67% D+
Trailing 5 Years  
Capital Gain 99.40% 89% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 99.40% 88% B+ 84% B
Average Annual (5 Year Horizon)  
Capital Gain 20.07% 82% B 64% D
Dividend Return 20.07% 82% B 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.97% 54% F 92% A
Risk Adjusted Return 125.68% 100% F 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike